Form 8-K EXACT SCIENCES CORP For: Feb 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Exact Sciences (EXAS) PT Lowered to $65 at BTIG
February 20, 2025 6:47 AM ESTBTIG analyst Mark Massaro lowered the price target on Exact Sciences (NASDAQ: EXAS) to $65.00 (from $75.00) while maintaining a Buy rating.
The analyst comments "Consistent with the company's pre-announce last month, EXAS delivered a modest Q4 revenue beat, as screening and precision oncology in 2024 grew +13% and +4% Y/Y, respectively. In... More
